technetium tc 99m mertiatide has been researched along with Benign Neoplasms in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (83.33) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alves, RJ; Cardoso, VN; de Barros, AL; Leite, EA; Mota, Ld; Oliveira, MC | 1 |
| Allard, M; Azéma, L; Da Rocha Gomes, S; Dausse, E; Eimer, S; Loiseau, H; Miguel, J; Ries, C; Toulmé, JJ | 1 |
| Bruskin, A; Engfeldt, T; Karlström, AE; Orlova, A; Tolmachev, V; Tran, T; Widström, C | 1 |
| Di, LJ; Guo, FQ; Liu, HJ; Liu, M; Wang, RF; Yan, P; Yu, MM; Zhang, CL | 1 |
| McDougall, IR; Niederkohr, RD | 1 |
| Carrasquillo, JA; Jeong, HJ; Kao, CH; Kim, MK; Kobayashi, H; Paik, CH; Paik, DS; Pie, JE; Waldmann, TA; Yao, Z | 1 |
1 review(s) available for technetium tc 99m mertiatide and Benign Neoplasms
| Article | Year |
|---|---|
Incidental gallbladder visualization on nonhepatobiliary nuclear medicine studies: case series and review of the literature.
Topics: Diagnosis, Differential; False Positive Reactions; Female; Gallbladder; Humans; Hydronephrosis; Incidental Findings; Isotope Labeling; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasms; Nuclear Medicine; Pancreatic Diseases; Radiopharmaceuticals; Sensitivity and Specificity; Somatostatin; Technetium Tc 99m Mertiatide; Tomography, Emission-Computed | 2007 |
5 other study(ies) available for technetium tc 99m mertiatide and Benign Neoplasms
| Article | Year |
|---|---|
Synthesis and biological evaluation of technetium-labeled D-glucose-MAG3 derivative as agent for tumor diagnosis.
Topics: Animals; Chemistry, Pharmaceutical; Drug Design; Glucose; Mice; Models, Chemical; Neoplasm Transplantation; Neoplasms; Neoplasms, Experimental; Radiopharmaceuticals; Solvents; Technetium; Technetium Tc 99m Mertiatide; Tissue Distribution | 2009 |
(99m)Tc-MAG3-aptamer for imaging human tumors associated with high level of matrix metalloprotease-9.
Topics: Aptamers, Nucleotide; Humans; Immunohistochemistry; Matrix Metalloproteinase 9; Molecular Structure; Neoplasms; Radiopharmaceuticals; Technetium Tc 99m Mertiatide | 2012 |
Imaging of HER2-expressing tumours using a synthetic Affibody molecule containing the 99mTc-chelating mercaptoacetyl-glycyl-glycyl-glycyl (MAG3) sequence.
Topics: Animals; Antibodies; Biosensing Techniques; Cell Line, Tumor; Female; Humans; Mice; Mice, Inbred BALB C; Neoplasm Transplantation; Neoplasms; Peptides; Radionuclide Imaging; Radiopharmaceuticals; Receptor, ErbB-2; Spectrometry, Mass, Electrospray Ionization; Technetium Tc 99m Mertiatide | 2007 |
Noninvasive imaging of human telomerase reverse transcriptase (hTERT) messenger RNA with 99mTc-radiolabeled antisense probes in malignant tumors.
Topics: Animals; Cell Line, Tumor; Drug Stability; Female; Humans; Isotope Labeling; Mice; Mice, Inbred BALB C; Neoplasm Transplantation; Neoplasms; Oligonucleotides, Antisense; Radionuclide Imaging; Radiopharmaceuticals; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Technetium Tc 99m Mertiatide; Telomerase; Tissue Distribution; Transplantation, Heterologous | 2007 |
Improved renal clearance and tumor targeting of 99mTc-labeled anti-Tac monoclonal antibody Fab by chemical modifications.
Topics: Animals; Antibodies, Monoclonal; Female; Glycolates; Hydrogen-Ion Concentration; Immunoglobulin Fab Fragments; Iodine Radioisotopes; Kidney; Lysine; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasms; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Mertiatide; Tissue Distribution | 2002 |